Hawthorne, NY, United States of America

Pei-Yun S Hsueh

This inventor holds 18 USPTO granted patents and 6 published patent applications, primarily in Patient Engagement Technology. Top assignees: International Business Machines Corporation, Institute of Bioengineering and Nanotechnology. Active years: 2012-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pei-Yun S Hsueh. Retrieved from https://idiyas.com/inventor/pei-yun-s-hsueh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 

% Patents Active = 55.6

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • White Plains, NY (US) (2012)
  • Hawthorne, NY (US) (2018 - 2021)
  • New York, NY (US) (2017 - 2024)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Areas of Expertise:
Personalized Medication
Biofilm Formation
Patient Engagement
Collaborative Medical Concepts
Risk Stratification
Sensor Data
Behavioral Phenotypes
EEG Technology
Flow Monitoring
Graph Analysis
Eye Recovery Tracking
18 patents (USPTO):Explore Patents

Title: The Innovations of Pei-Yun S Hsueh: A Pioneer in Personalized Medicine and Antibacterial Coatings

Introduction

Pei-Yun S Hsueh is an accomplished inventor based in Hawthorne, NY, with an impressive portfolio of 18 patents. His work focuses primarily on advancements in personalized medicine and antibacterial technologies. Hsueh’s innovations address critical health issues, providing effective solutions that enhance patient care and combat healthcare-associated challenges.

Latest Patents

Among Hsueh's notable contributions are two significant patents. The first is a method, computer program product, and computer system for personalized medication non-adherence evaluation. This innovative approach entails identifying risk factors associated with a patient's medication adherence, predicting their likely behavior based on these factors, and determining both current and future medication adherence values. This cutting-edge method utilizes a temporal causal model, enhancing its predictive accuracy and applicability in clinical settings.

His second recent patent focuses on the prevention of biofilm formation through the development of antibacterial coatings. This patent describes a unique multilayer system where a branched polyethylenimine layer is combined with glyoxal to create a crosslinked BPEI coating. This technology can be tailored with varying chemical moieties to improve its antifouling and bactericidal characteristics, making it a significant advancement in material science applicable across medical and industrial environments.

Career Highlights

Pei-Yun S Hsueh's career includes noteworthy positions at leading organizations such as IBM and the Institute of Bioengineering and Nanotechnology. His experience in these institutions has allowed him to contribute to groundbreaking research and innovation in his field, marking him as a leader in biomedical engineering and nanotechnology.

Collaborations

Throughout his career, Hsueh has collaborated with esteemed colleagues such as Amos Cahan and Hariklia Deligianni, a talented woman in the field. These partnerships have further enriched his work, fostering an environment of creativity and shared knowledge that has propelled many successful innovations.

Conclusion

With 18 patents to his name, Pei-Yun S Hsueh exemplifies creativity and scientific advancement in personalized medicine and antibacterial technologies. His latest inventions showcase the potential of his work in enhancing patient outcomes and addressing pressing health challenges. As he continues to innovate, Hsueh's contributions will undoubtedly have a lasting impact on the medical and research communities.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…